Background: The aim of this study was to assess the safety and surgical results of femtosecond laser-assisted phacovitrectomy. Methods: A retrospective analysis of the medical records of patients over 50 years of age with vitreoretinal pathology, who had undergone pars plana vitrectomy using 23-gauge instruments and femtosecond laser-assisted cataract surgery and implantation of an intraocular lens, was performed at the Instituto de Microcirugía Ocular between June 2012 and September 2013. The diameter of the anterior capsulorhexis was set at 4.8 mm in cases where a gas tamponade was used and at 5 mm in all other cases. During the pars plana vitrectomy, posterior capsulotomy was performed on all eyes. An assessment was carried out of preoperative characteristics, surgical indications, postoperative results and complications. Only patients with a minimum of 3 months of follow-up were included. Results: A total of 21 eyes in 21 patients (71.4% women) were treated. Mean age (±SD) was 65.8 ± 6.4 years (range 53-76). The most common indication for surgery was epiretinal membrane (61.9%), followed by vitreous haemorrhage (23.8%) and macular hole (14.3%). The mean preoperative best corrected visual acuity (BCVA) was 0.81 ± 1.01 logMAR and the mean postoperative BCVA was 0.12 ± 0.19 logMAR (p = 0.003). 85.7% of patients improved their visual acuity. The remaining patients maintained their visual acuity. The only intraoperative complication related to femtosecond laser was 1 case of suction loss (4.8%). A patient with rhegmatogenous retinal detachment discovered during surgery required an additional circular scleral procedure and developed synechiaes in the early postoperative period (<1 month). There were no cases of subluxation of the intraocular lens. Mean follow-up was 6 months (range 3-14). Conclusions: The application of femtosecond laser in phacovitrectomy is a safe and effective technique that presents advantages compared to conventional techniques in cases of macular pathology and/or vitreous haemorrhage.

Hsuan JD, Brown NA, Bron AJ, et al: Posterior subcapsular and nuclear cataract after vitrectomy. J Cataract Refract Surg 2001;27:437-444.
Hwang J, Yoon YH, Kim DS, Kim JG: Combined phacoemulsification, foldable intraocular lens implantation, and 25-gauge transconjunctival sutureless vitrectomy. J Cataract Refract Surg 2006;32:727-731.
Shousha MA, Yoo SH: Cataract surgery after pars plana vitrectomy. Curr Opin Ophthalmol 2010;21:45-49.
Sisk RA, Murray TG: Combined phacoemulsification and sutureless 23-gauge pars plana vitrectomy for complex vitreoretinal diseases. Br J Ophthalmol 2010;94:1028-1032.
Nagy ZZ, Takacs AI, Filkorn T, Kránitz K, Gyenes A, Juhász E, Sándor GL, Kovacs I, Juhász T, Slade S: Complications of femtosecond laser-assisted cataract surgery. J Cataract Refract Surg 2014;40:20-28.
Donaldson KE, Braga-Mele R, Cabot F, Davidson R, Dhaliwal DK, Hamilton R, Jackson M, Patterson L, Stonecipher K, Yoo SH; ASCRS Refractive Cataract Surgery Subcommittee: Femtosecond laser-assisted cataract surgery. J Cataract Refract Surg 2013;39:1753-1763.
Dick HB, Schultz T: On the way to zero phaco. J Cataract Refract Surg 2013;39:1442-1444.
Conrad-Hengerer I, Al Juburi M, Schultz T, Hengerer FH, Dick HB: Corneal endothelial cell loss and corneal thickness in conventional compared with femtosecond laser-assisted cataract surgery: three-month follow-up. J Cataract Refract Surg 2013;39:1307-1313.
Bali SJ, Hodge C, Chen S, Sutton G: Femtosecond laser assisted cataract surgery in phacovitrectomy. Graefes Arch Clin Exp Ophthalmol 2012;250:1549-1551.
Faulborn J, Conway BP, Machemer R: Surgical complications of pars plana vitreous surgery. Ophthalmology 1978;85:116-125.
Li W, Sun G, Wu R, Wang X, Xu M, Sun C: Longterm results after phacovitrectomy and foldable intraocular lens implantation. Acta Ophthalmol 2009;87:896-900.
Zheng QX, Wu RH, Zhang YP, Xu M, Li WS: Anterior segment complications after phacoemulsification combined vitrectomy and foldable intraocular lens implantation. Int J Ophthalmol 2010;3:249-254.
Wu Z, Zhang J, Chen Y, Gao R, Lin Z: Efficacy of phacovitrectomy combined with internal limiting membrane peeling for macular diseases. Eye Sci 2012;27:25-29.
Tseng HT, Wu WC, Hsu SY: Comparison of vitrectomy alone and combined vitrectomy, phacoemulsification and intraocular lens implantation for proliferative diabetic retinopathy. Kaohsiung Med Sci 2007;23:339-343.
Kim NJ, Yu HG: A phacovitrectomy with a clear corneal incision for a full-thickness macular hole. Korean J Ophthalmol 2006;20:147-150.
Chaundhry NA, Cohen KA, Flynn HW Jr, Murray TG: Combined pars plana vitrectomy and lens management in complex vitreoretinal disease. Semin Ophthalmol 2003;18:132-141.
Blankenship GW, Flynn HW Jr, Kokame GT: Posterior chamber intraocular lens insertion during pars plana lensectomy and vitrectomy for complications of proliferative diabetic retinopathy. Am J Ophthalmol 1989;108:1-5.
Smith M, Raman SV, Pappas G, Simcock P, Ling R, Shaw S: Phacovitrectomy for primary retinal detachment repair in presbyopes. Retina 2007;27:462-467.
Cavallini GM, Pupino A, Masini C, Campi L, Pelloni S: Bimanual microphacoemulsification and Acri Smart intraocular lens implantation combined with vitreoretinal surgery. J Cataract Refract Surg 2007;33:1253-1258.
Smith M, Raman SV, Pappas G, Simcock P, Ling R, Shaw S: Phacovitrectomy for primary retinal detachment repair in presbyopes. Retina 2007;27:462-467.
Rahman R, Bong CX, Stephenson J: Accuracy of intraocular lens power estimation in eyes having phacovitrectomy for rhegmatogenous retinal detachment. Retina 2014;34:1415-1420.
Iwase T, Oveson BC, Nishi Y: Posterior capsule opacification following 20- and 23-gauge phacovitrectomy (posterior capsule opacification following phacovitrectomy). Eye 2012;26:1459-1464.
Rahman R, Briffa BV, Gupta A, Chinn DJ: Factors contributing to posterior capsule opacification following 23-gauge transconjunctival phacovitrectomy. Ophthalmic Surg Lasers Imaging 2011;42:229-233.
Ling CA, Weiter JJ, Buzney SM, Laskari K: Competing theories of cataractogenesis after pars plana vitrectomy and the nutrient theory of cataractogenesis: a function of altered aqueous fluid dynamics. Int Ophthalmol Clin 2005;45:173-198.
Toda J, Kato S, Oshika T, Sugita G: Posterior capsule opacification after combined cataract surgery and vitrectomy. J Cataract Refract Surg 2007;33:104-107.
Sato S, Inoue M, Kobayashi S, Watanabe Y, Kadonosono K: Primary posterior capsulotomy using a 25-gauge vitreous cutter in vitrectomy combined with cataract surgery. J Cataract Refract Surg 2010;36:2-5.
Helbig H, Kellner U, Bornfeld N, Foerster MH: Cataract surgery and YAG-laser capsulotomy following vitrectomy for diabetic retinopathy. Ger J Ophthalmol 1996;5:408-414.
Kumar A, Goyal M, Tewari HK: Posterior segment visualization problems with multifocal intraocular lenses. Acta Ophthalmol Scand 1996;74:415.
Demetriades AM, Gottsch JD, Thomsen T, et al: Combined phacoemulsification, intraocular lens implantation, and vitrectomy for eyes with coexisting cataract and vitreoretinal pathology. Am J Ophthalmol 2003;135:291-296.
Yamamoto N, Ozaki N, Murakami K: Trypan-blue and endoillumination-assisted phacoemulsification in eyes with vitreous hemorrhage during combined cataract and vitreous surgery. Ophthalmologica 2005;219:338-344.
Lee VYW, Kwok AKH: Multiport-illumination-system-assisted phacoemulsification in eyes with dense vitreous hemorrhage during combined cataract and vitreous surgery. J Cataract Refract Surg 2003;29:1252-1255.
Oshima Y, Shima C, Maeda N, Tano Y: Chandelier retroillumination-assisted torsional oscillation for cataract surgery in patients with severe corneal opacity. J Cataract Refract Surg 2007;33:2018-2022.
Kim KH, Sohn HJ, Song HJ, Lee DY, Nam DH: Surgeon-controlled-endoillumination-guided irrigation and aspiration during combined 23-gauge sutureless vitrectomy and cataract surgery in eyes with poor fundus reflex. J Cataract Refract Surg 2010;36:2028-2031.
Schultz T, Dick HB: Suction loss during femtosecond laser-assisted cataract surgery. J Cataract Refract Surg 2014;40:493-495.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.